Pulsatile LVAS implantation significantly improved estimated glomerular filtration rate (42.7 to 64.1 mL/min, P<0.05) and renal vascular resistance (0.79 to 0.60, P<0.01) in advanced heart failure.
Observational (n=5)
Tasa de eventos absoluta: 64.1% vs 42.7%
valor p: p=<0.05
The effects of left ventricular assist system (LVAS) implantation on renal hemodynamics remains to be fully elucidated. We evaluated renal function and intrarenal blood flow in five advanced heart failure patients who had been supported with a Toyobo LVAS for bridge to heart transplantation. Renal function expressed as estimated glomerular filtration rate (eGFR) was calculated using the modified formula of Modification of Diet in Renal Disease. Mean blood velocities in the bilateral segmental arteries during systolic and diastolic perfusion were measured using duplex Doppler sonography, and renal vascular resistance (resistive index RI) of the segmental arteries was defined as (peak systolic velocity PSV-end-diastolic velocity EDV)/PSV. All studies were performed before and after implantation (mean duration of support, 15.6±10.9 months). LVAS implantation significantly improved eGFR (42.7±7.9 to 64.1±16.3mL/min, P<0.05). Beat-by-beat measurements of heart rate did not change significantly. Mean PSV decreased significantly (38.2±8.9 to 28.3±2.2cm/s, P<0.05), and mean EDV increased significantly (8.3±3.2 to 11.3±1.3cm/s, P<0.05), and thus, mean RI was significantly improved (0.79±0.06 to 0.60±0.04, P<0.01). In conclusion, in advanced heart failure patients, pulsatile LVAS implantation is associated with improved renal function, and this improvement may be mediated in part through an improvement of intrarenal hemodynamics.
Iwashima et al. (Fri,) conducted a observational in Advanced heart failure (n=5). Pulsatile left ventricular assist system (LVAS) implantation vs. Before implantation (baseline) was evaluated on Estimated glomerular filtration rate (eGFR) (p=<0.05). Pulsatile LVAS implantation significantly improved estimated glomerular filtration rate (42.7 to 64.1 mL/min, P<0.05) and renal vascular resistance (0.79 to 0.60, P<0.01) in advanced heart failure.